rheumatology
Medicines

TGA dumps biosimilar naming convention

The TGA says it will not be continuing with its naming convention for biosimilars because of ‘international developments’. In July 2013 the TGA published guidance on biosimilar naming based upon the combination of a WHO Programme on International Nonproprietary Names (INN) issued biosimilar identifier with the Australian biological name (ABN). In July 2014 the WHO ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic